The Allstate Co. (NYSE:ALL) Shares Sold by Swiss National Bank

Swiss National Bank trimmed its stake in shares of The Allstate Co. (NYSE:ALL) by 3.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 818,000 shares of the insurance provider’s stock after selling 27,500 shares during the period. Swiss National Bank’s holdings in Allstate were worth $114,504,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also bought and sold shares of ALL. Gradient Investments LLC grew its holdings in Allstate by 1.6% in the fourth quarter. Gradient Investments LLC now owns 4,130 shares of the insurance provider’s stock valued at $578,000 after purchasing an additional 66 shares during the period. Brighton Jones LLC grew its position in shares of Allstate by 1.9% in the fourth quarter. Brighton Jones LLC now owns 3,862 shares of the insurance provider’s stock valued at $541,000 after purchasing an additional 71 shares in the last quarter. SVB Wealth LLC increased its holdings in shares of Allstate by 1.2% in the fourth quarter. SVB Wealth LLC now owns 6,169 shares of the insurance provider’s stock valued at $864,000 after purchasing an additional 72 shares during the last quarter. AdvisorNet Financial Inc boosted its stake in Allstate by 1.5% during the fourth quarter. AdvisorNet Financial Inc now owns 5,384 shares of the insurance provider’s stock worth $754,000 after buying an additional 82 shares during the last quarter. Finally, Carmel Capital Partners LLC increased its stake in shares of Allstate by 19.2% in the 3rd quarter. Carmel Capital Partners LLC now owns 516 shares of the insurance provider’s stock worth $57,000 after acquiring an additional 83 shares during the last quarter. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Insider Buying and Selling at Allstate

In other news, CAO John C. Pintozzi sold 4,000 shares of Allstate stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $159.47, for a total value of $637,880.00. Following the transaction, the chief accounting officer now directly owns 10,736 shares of the company’s stock, valued at approximately $1,712,069.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Allstate news, insider John E. Dugenske sold 31,000 shares of the stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at an average price of $170.20, for a total transaction of $5,276,200.00. Following the completion of the sale, the insider now directly owns 63,731 shares of the company’s stock, valued at approximately $10,847,016.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO John C. Pintozzi sold 4,000 shares of the company’s stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $159.47, for a total transaction of $637,880.00. Following the transaction, the chief accounting officer now owns 10,736 shares of the company’s stock, valued at approximately $1,712,069.92. The disclosure for this sale can be found here. 1.80% of the stock is owned by company insiders.

Allstate Stock Down 0.6 %

ALL stock opened at $168.18 on Friday. The stock has a market cap of $44.39 billion, a P/E ratio of 37.13, a PEG ratio of 0.40 and a beta of 0.51. The company has a current ratio of 0.36, a quick ratio of 0.37 and a debt-to-equity ratio of 0.48. The Allstate Co. has a twelve month low of $100.57 and a twelve month high of $177.37. The company’s 50 day moving average is $165.88 and its two-hundred day moving average is $150.65.

Allstate (NYSE:ALL) last announced its quarterly earnings results on Wednesday, May 1st. The insurance provider reported $5.13 EPS for the quarter, topping the consensus estimate of $4.11 by $1.02. Allstate had a net margin of 2.31% and a return on equity of 14.44%. The firm had revenue of $15.26 billion for the quarter, compared to analyst estimates of $12.76 billion. During the same period last year, the business earned ($1.30) EPS. Allstate’s revenue for the quarter was up 10.7% compared to the same quarter last year. Research analysts expect that The Allstate Co. will post 14.04 earnings per share for the current fiscal year.

Allstate Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, April 1st. Investors of record on Monday, March 4th were paid a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a yield of 2.19%. The ex-dividend date of this dividend was Friday, March 1st. This is an increase from Allstate’s previous quarterly dividend of $0.89. Allstate’s dividend payout ratio (DPR) is currently 81.24%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on ALL. Morgan Stanley lifted their price target on shares of Allstate from $187.00 to $190.00 and gave the company an “overweight” rating in a research report on Monday, April 15th. Piper Sandler lifted their target price on Allstate from $172.00 to $188.00 and gave the company an “overweight” rating in a research report on Monday, April 1st. UBS Group increased their price target on Allstate from $171.00 to $185.00 and gave the stock a “buy” rating in a report on Monday, February 12th. HSBC upgraded shares of Allstate from a “hold” rating to a “buy” rating and lifted their target price for the company from $158.00 to $190.00 in a report on Thursday, March 28th. Finally, BMO Capital Markets lifted their target price on Allstate from $140.00 to $158.00 and gave the company a “market perform” rating in a research report on Friday, January 19th. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Allstate presently has a consensus rating of “Moderate Buy” and a consensus target price of $174.18.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.